Inventor · disambiguated record
Brian William Dymock
Also filed as: DYMOCK BRIAN · DYMOCK BRIAN W · DYMOCK BRIAN WILLIAM
27 granted patents·6 pending applications·183 citations·filing 2001–2023
96Inventor score
Files withVERNALIS CAMBRIDGE LTD8DRYSDALE MARTIN JAMES4HOFFMANN LA ROCHE4DYMOCK BRIAN3VERNALIS R&D LTD3
Top patents by PatentIndex Score
33 records- 0192US7189718B2Non-nucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2004·Granted Mar 13, 2007·33 cites·40 claims
- 0286US8507480B2Isoxazole compounds as inhibitors of heat shock proteinsDRYSDALE MARTIN JAMES·Filed 2010·Granted Aug 13, 2013·8 cites·30 claims
- 0386US7612201B2Pyrazole compoundsVERNALIS CAMBRIDGE LTD·Filed 2003·Granted Nov 3, 2009·31 cites·7 claims
- 0484US9120815B2Solid state forms of macrocyclic kinase inhibitorsMANSFIELD ROBERT K·Filed 2011·Granted Sep 1, 2015·9 cites·16 claims
- 0584US8450310B2Isoxazole compounds as inhibitors of heat shock proteinsDRYSDALE MARTIN JAMES·Filed 2012·Granted May 28, 2013·6 cites·29 claims
- 0682US10413550B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2017·Granted Sep 17, 2019·2 cites·28 claims
- 0782US7632855B2Pyrazole compounds as HSP90 inhibitors for the treatment of cancerVERNALIS CAMBRIDGE LTD·Filed 2004·Granted Dec 15, 2009·26 cites·20 claims
- 0880US9718793B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2013·Granted Aug 1, 2017·3 cites·29 claims
- 0980US7247734B23,4-diarylpyrazoles and their use in the therapy of cancerINST OF CANCER RES OF ROYAL CA·Filed 2002·Granted Jul 24, 2007·19 cites·20 claims
- 1078US6538015B1Anti-HIV pyrazole derivativesHOFFMANN LA ROCHE·Filed 2002·Granted Mar 25, 2003·9 cites·9 claims
- 1177US7705027B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS CAMBRIDGE LTD·Filed 2004·Granted Apr 27, 2010·7 cites·34 claims
- 1276US11234987B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2019·Granted Feb 1, 2022·0 cites·29 claims
- 1374US7820658B2Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitorsVERNALIS CAMBRIDGE LTD·Filed 2004·Granted Oct 26, 2010·9 cites·23 claims
- 1473US6737429B2Pyrrole derivativesHOFFMANN LA ROCHE·Filed 2001·Granted May 18, 2004·7 cites·26 claims
- 1570US8980873B211-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate saltDYMOCK BRIAN·Filed 2009·Granted Mar 17, 2015·1 cites·13 claims
- 1668US8642594B2Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitorsDYMOCK BRIAN WILLIAM·Filed 2010·Granted Feb 4, 2014·3 cites·15 claims
- 1768US7728016B2Substituted 5-membered ring compounds and their useVERNALIS CAMBRIDGE LTD·Filed 2004·Granted Jun 1, 2010·4 cites·6 claims
- 1867US7803831B23-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitors for the treatment of cancerVERNALIS CAMBRIDGE LTD·Filed 2003·Granted Sep 28, 2010·4 cites·18 claims
- 1962US8163747B2Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these formsDRYSDALE MARTIN JAMES·Filed 2008·Granted Apr 24, 2012·0 cites·17 claims
- 2062US7183296B2Anti-HIV pyrazole derivativesROCHE PALO ALTO LLC·Filed 2004·Granted Feb 27, 2007·1 cites·12 claims
- 2161US6518293B2Anti-HIV imidazolone derivativesHOFFMANN LA ROCHE·Filed 2001·Granted Feb 11, 2003·1 cites·14 claims
- 2258US8987243B211-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-maleate saltDYMOCK BRIAN·Filed 2009·Granted Mar 24, 2015·0 cites·14 claims
- 2356US8487095B2Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-iso-propyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these formsDRYSDALE MARTIN JAMES·Filed 2012·Granted Jul 16, 2013·0 cites·3 claims
- 2456US2025263408A1Spleen tyrosine kinase inhibitorsUNIQUEST PTY LTD·Filed 2023·Application pending·0 cites
- 2550US2007213328A1Pyridothiophene CompoundsVERNALIS CAMBRIDGE LTD·Filed 2004·Application pending·0 cites
- 2650US2004110718A1Anti-HCV nucleoside derivativesFiled 2003·Application pending·0 cites
- 2749US2023218589A1Compound for prevention or treatment of a skin cancer or skin precancerUNIQUEST PTY LTD·Filed 2021·Application pending·0 cites
- 2846US6699887B2Anti-HIV pyrazole derivativesHOFFMANN LA ROCHE·Filed 2001·Granted Mar 2, 2004·0 cites·11 claims
- 2945US2003008841A1Anti-HCV nucleoside derivativesFiled 2001·Application pending·0 cites
- 3042US2011034457A1Pyridothiophene CompoundsVERNALIS CAMBRIDGE LTD·Filed 2010·Application pending·0 cites
- 3141US9062074B2(9E)-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2.5).1(14,18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate saltDYMOCK BRIAN·Filed 2010·Granted Jun 23, 2015·0 cites·14 claims
- 3239US9624242B211-2(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate saltCTI BIOPHARMA CORP·Filed 2015·Granted Apr 18, 2017·0 cites·11 claims
- 3331US10308631B2Selective anti-cancer compoundsNAT UNIV SINGAPORE·Filed 2016·Granted Jun 4, 2019·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →